Advances in Inflammatory Bowel Diseases (AIBD 2017) is a conference that covers topics such as:
Pediatric Clinical
Investigator-initiated Uncontrolled Clinical Trials
Investigator-initiated Controlled Clinical Trials
Procedures and Diagnostics
Pharma-initiated Clinical Trials
Patient Care and Complications of Therapy
Epidemiology and Outcomes Research
Pediatric Surgery
Clinical Case Reports
Clinical
Investigator-initiated Uncontrolled Clinical Trials
Investigator-initiated Controlled Clinical Trials
Procedures and Diagnostics
Pharma-initiated Clinical Trials
Patient Care and Complications of Therapy
Epidemiology and Outcomes Research
Surgery
Clinical Case Reports
Nursing
Clinical Basic Research
Clinical Education
Clinical Practice
Basic Research
Microbiology
Genetics
Adaptive Immune System
Innate Immune System
Epithelial Cells
Cytokines, Chemokines, and Cell Signaling
Animal Models
Abstracts will be accepted in the following categories: CLINICAL or PEDIATRIC or NURSING. Please indicate which category is appropriate by checking the appropriate box in the online submission system.
Clinical Abstract Categories
C1. Investigator-initiated Controlled Clinical Trials
C2. Investigator-initiated Uncontrolled Clinical Trials
C3. Pharma-initiated Clinical Trials
C4. Procedures and Diagnostics
C5. Epidemiology and Outcomes Research
C6. Patient Care and Complications of Therapy
C7. Clinical Case Reports
C8. Surgery
Pediatric Clinical Abstract Categories
P1. Investigator-initiated Controlled Clinical Trials
P2. Investigator-initiated Uncontrolled Clinical Trials
P3. Pharma-initiated Clinical Trials
P4. Procedures and Diagnostics
P5. Epidemiology and Outcomes Research
P6. Patient Care and Complications of Therapy
P7. Clinical Case Reports
P8. Surgery
Nursing Abstract Categories
N1. Clinical Education
N2. Clinical Basic Research
N3. Clinical Practice
N4. Other
Accepted format:
Abstracts must be in English
9 point Arial font
500 word count limit
Use a concise title in title case only
List affiliations of author(s) as briefly as possible, with city, province and country
Use standard and well-accepted abbreviations
When listing references, use standard and well-accepted formats
Abstract content should be single-spaced and typed in lower case
Abstracts shall be of original research and contain a concise statement of study aim
Please include the following four (4) parts of your abstract:
Background, Methods, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable
Previous Presentation, Publication and Duplication of Abstracts:
Abstracts will not be considered for presentation if they have been or will be presented before the 2017 Advances in IBD Conference.
Abstracts will not be considered for presentation if they have been or will be published as an article (includes manuscripts accepted for publication) in either printed or electronic format upon the abstract submission deadline.
Abstracts will not be considered for presentation if they have been duplicated in any way.
Abstracts may not be submitted to more than one category.
Abstracts that have been submitted to the Advances in IBD Conference in previous years, and have not been accepted for poster or oral presentation, are eligible for submission but must contain new, additional information to be considered.
Violations of these policies could result in a sanction from submitting abstracts to this conference for the submitting author.
Presentation Formats
Oral presentations
Poster presentations
Abstracts for oral or poster presentations will be chosen by the Scientific Review Committee.
Oral Abstract Presentation: Oral abstracts will be 10 minute presentations, which is the total allotted time. Therefore presenters must plan accordingly to schedule audience participation and questions. Employees of commercial interests are not preferred oral abstract presenters, but authors on the abstract who are not employees of commercial interests are eligible to present their data, if selected.
Poster Abstract Presentation: Poster presentations encourage interaction and exchange between authors and attendees. Detailed information regarding presentation times will be forthcoming.
11月09日
2017
11月11日
2017
摘要截稿日期
摘要录用通知日期
注册截止日期
留言